{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:44:36Z","timestamp":1785840276610,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1TR004405"],"award-info":[{"award-number":["UM1TR004405"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eprac.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:14:18Z","timestamp":1776726858000},"page":"1227-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Agreement Between HbA1C and Continuous Glucose Monitoring\u2013Derived Glycemic Metrics in Adults With Cystic Fibrosis Related Diabetes"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9520-0455","authenticated-orcid":false,"given":"Ammar","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Batth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Vigers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Larson","family":"Ode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Moheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2026.04.007_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.eprac.2026.04.007_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1164\/rccm.202104-1060LE","article-title":"Cystic fibrosis\u2013related diabetes is associated with worse lung function trajectory despite ivacaftor use","volume":"204","author":"Bengtson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"7258","key":"10.1016\/j.eprac.2026.04.007_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.007_bib4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-011-2404-1","article-title":"Association of HbA1C levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds","volume":"55","author":"Zoungas","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.007_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19666","article-title":"Association of longitudinal values of glycated hemoglobin with cardiovascular events in patients with type 2 diabetes and multivessel coronary artery disease","volume":"3","author":"Rezende","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"13","key":"10.1016\/j.eprac.2026.04.007_bib6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra2311526","article-title":"Prevention of cardiovascular disease in type 1 diabetes","volume":"390","author":"Manrique-Acevedo","year":"2024","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1016\/j.eprac.2026.04.007_bib7","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.2337\/dc22-0239","article-title":"Impact of HbA1C followed 32 years from diagnosis of type 1 diabetes on development of severe retinopathy and nephropathy: the VISS study","volume":"45","author":"Arnqvist","year":"2022","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2026.04.007_bib8","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis\u2013related diabetes","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.007_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250036","article-title":"Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis","volume":"16","author":"Darukhanavala","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.007_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.diabet.2008.05.010","article-title":"No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes","volume":"34","author":"Godbout","year":"2008","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.007_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcf.2005.09.001","article-title":"Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis","volume":"5","author":"Brennan","year":"2006","journal-title":"J Cystic Fibrosis"},{"issue":"8","key":"10.1016\/j.eprac.2026.04.007_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/pedi.12914","article-title":"Screening for cystic fibrosis-related diabetes and prediabetes: evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c","volume":"20","author":"Tommerdahl","year":"2019","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2026.04.007_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jcf.2025.11.003","article-title":"Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1C in cystic fibrosis","volume":"25","author":"Alexandre-Heymann","year":"2026","journal-title":"J Cystic Fibrosis"},{"issue":"4, Part 2 of 2","key":"10.1016\/j.eprac.2026.04.007_bib14","first-page":"90A","article-title":"Accelerated red blood cell turnover can invalidate the use of hemoglobin A1c as a diagnostic test for cystic fibrosis related diabetes","volume":"45","author":"Hardin","year":"1999","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.eprac.2026.04.007_bib15","first-page":"153","article-title":"Ferrokinetic and hematologic studies in cystic fibrosis patients","volume":"5","author":"Wagener","year":"1983","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"7","key":"10.1016\/j.eprac.2026.04.007_bib16","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc17-2419","article-title":"Hemoglobin A1c accurately predicts continuous glucose monitoring\u2013derived average glucose in youth and young adults with cystic fibrosis","volume":"41","author":"Chan","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.007_bib17","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1C in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.007_bib18","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2337\/dc25-2936","article-title":"Relationship between laboratory-measured HbA1C and continuous glucose monitoring-derived glucose management indicator in adults with cystic fibrosis-related diabetes","volume":"49","author":"Kadiyala","year":"2026","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.007_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002573","article-title":"Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review","volume":"10","author":"Raj","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"11","key":"10.1016\/j.eprac.2026.04.007_bib20","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.007_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinchem\/hvac210","article-title":"Performance of the Glucose Management Indicator (GMI) in type 2 diabetes","volume":"69","author":"Fang","year":"2023","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.007_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/19322968241262106","article-title":"Differences between glycated hemoglobin and glucose management indicator in real-time and intermittent scanning continuous glucose monitoring in adults with type 1 diabetes","volume":"20","author":"Yoo","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.eprac.2026.04.007_bib23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"359","key":"10.1016\/j.eprac.2026.04.007_bib25","doi-asserted-by":"crossref","first-page":"359ra130","DOI":"10.1126\/scitranslmed.aaf9304","article-title":"Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring","volume":"8","author":"Malka","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.eprac.2026.04.007_bib26","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: improving Global Outcomes (KDIGO)","volume":"45","author":"Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.04.007_bib27","first-page":"S306","article-title":"15. Management of diabetes in pregnancy: Standards of Care in Diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:54:28Z","timestamp":1785837268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26009547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1530891X26009547"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.04.007","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agreement Between HbA1C and Continuous Glucose Monitoring\u2013Derived Glycemic Metrics in Adults With Cystic Fibrosis Related Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}